Detalhe da pesquisa
1.
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
Headache
; 61(3): 438-454, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594686
2.
A Controlled Trial of Erenumab for Episodic Migraine.
N Engl J Med
; 377(22): 2123-2132, 2017 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171821
3.
Migraine day frequency in migraine prevention: longitudinal modelling approaches.
BMC Med Res Methodol
; 19(1): 20, 2019 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674285
4.
Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Headache
; 59(5): 715-726, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861110
5.
Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.
Health Qual Life Outcomes
; 17(1): 171, 2019 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718662
6.
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
Cephalalgia
; 38(10): 1622-1631, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30086681
7.
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Headache
; 58(5): 700-714, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446063
8.
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
Headache
; 58(9): 1358-1372, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362524
9.
Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
Headache
; 57(9): 1385-1398, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857154
10.
Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
Health Qual Life Outcomes
; 15(1): 224, 2017 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29149901
11.
Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.
Health Qual Life Outcomes
; 14(1): 143, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716228
12.
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diary.
Qual Life Res
; 23(5): 1489-96, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379136
13.
Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study.
BMC Health Serv Res
; 14: 429, 2014 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249187
14.
Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study.
Front Oncol
; 13: 1274659, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38144529
15.
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies.
J Natl Cancer Inst
; 115(5): 586-596, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715639
16.
Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study.
Eur J Health Econ
; 24(3): 321-333, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610398
17.
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
J Adv Pract Oncol
; 14(6): 503-518, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808071
18.
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis.
Expert Rev Hematol
; 14(12): 1137-1145, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465265
19.
Care of asthma patients in relation to guidelines.
Allergy Asthma Proc
; 31(6): 452-60, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21708056
20.
Poor disease control among insured users of high-dose combination therapy for asthma.
Allergy Asthma Proc
; 31(1): 60-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20167146